Viewing Study NCT00577161


Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2025-12-27 @ 10:00 PM
Study NCT ID: NCT00577161
Status: WITHDRAWN
Last Update Posted: 2020-10-05
First Post: 2007-12-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
Sponsor: CTI BioPharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module